BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11600469)

  • 41. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.
    Grosen A; Nersting J; Bungum M; Christensen LA; Schmiegelow K; Spanò M; Julsgaard M; Cordelli E; Leter G; Larsen PB; Hvas CL; Kelsen J
    J Crohns Colitis; 2019 Jan; 13(1):3-11. PubMed ID: 29917107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
    Friedman AB; Brown SJ; Bampton P; Barclay ML; Chung A; Macrae FA; McKenzie J; Reynolds J; Gibson PR; Hanauer SB; Sparrow MP
    Aliment Pharmacol Ther; 2018 Apr; 47(8):1092-1102. PubMed ID: 29468701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease.
    Ding L; Zhang FB; Liu H; Gao X; Bi HC; Wang XD; Chen BL; Zhang Y; Zhao LZ; Zhong GP; Hu PJ; Chen MH; Huang M
    Inflamm Bowel Dis; 2012 Jan; 18(1):63-73. PubMed ID: 21381155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
    Ooi CY; Bohane TD; Lee D; Naidoo D; Day AS
    Aliment Pharmacol Ther; 2007 Apr; 25(8):941-7. PubMed ID: 17402998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
    Haglund S; Taipalensuu J; Peterson C; Almer S
    Br J Clin Pharmacol; 2008 Jan; 65(1):69-77. PubMed ID: 17662091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
    Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
    An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy.
    Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA
    J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Sánchez Rodríguez E; Ríos León R; Mesonero Gismero F; Albillos A; Lopez-Sanroman A
    Gastroenterol Hepatol; 2018 Dec; 41(10):629-635. PubMed ID: 30107940
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
    Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
    Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.
    Lee MN; Kang B; Choi SY; Kim MJ; Woo SY; Kim JW; Choe YH; Lee SY
    Inflamm Bowel Dis; 2015 Dec; 21(12):2897-908. PubMed ID: 26332308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Genetic polymorphism and treatment of chronic bowel inflammatory diseases: the example of azathioprine].
    Bessard G; Hardy G; Chartier A; Stanke-Labesque F
    Therapie; 2004; 59(1):71-5. PubMed ID: 15199672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation.
    Schütz E; Gummert J; Armstrong VW; Mohr FW; Oellerich M
    Eur J Clin Chem Clin Biochem; 1996 Mar; 34(3):199-205. PubMed ID: 8721407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study.
    Meijer B; Wilhelm AJ; Mulder CJJ; Bouma G; van Bodegraven AA; de Boer NKH
    Ther Drug Monit; 2017 Aug; 39(4):399-405. PubMed ID: 28489727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring.
    Caufield M; Tom WL
    J Am Acad Dermatol; 2013 Jan; 68(1):29-35. PubMed ID: 22892285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease.
    Dubinsky MC; Lamothe S; Yang HY; Targan SR; Sinnett D; Théorêt Y; Seidman EG
    Gastroenterology; 2000 Apr; 118(4):705-13. PubMed ID: 10734022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine: when less is more.
    Duley JA; Florin TH
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1317-9. PubMed ID: 18853992
    [No Abstract]   [Full Text] [Related]  

  • 59. Key factors associated with 6-thioguanine and 6-methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.
    de Beaumais TA; Lorrain S; Mamhoudi N; Simonin M; Martinez Vinson C; Medard Y; Petit A; Jacqz-Aigrain E
    Br J Clin Pharmacol; 2024 Jan; 90(1):209-219. PubMed ID: 37621013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.
    Gensmyr-Singer H; Werner M; Karling P
    Therap Adv Gastroenterol; 2024; 17():17562848241228064. PubMed ID: 38384282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.